New-Onset IBD and IL-17 Inhibitors: What Is the Risk? Underlying inflammatory disease severity should be taken into account Jul 21, 2021
FDA Approves IVIG for Dermatomyositis Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
Slow Steroid Tapering Succeeds in SLE Flare rates were significantly lower with gradual withdrawal than with low-dose maintenance Jul 13, 2021
Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
Pain Persists in RA, Even Without Inflammation At 5 years, one-third of patients with rheumatoid arthritis still had "unacceptable" pain Jun 22, 2021
Osteoarthritis: A Link With Parkinson's? Inflammation may contribute to both joint and nerve degeneration Jun 09, 2021
Secukinumab Shows Promise for Kids With Arthritis More than 90% responded at week 12, study showed Jun 07, 2021
Personalized Algorithm Helps Guide Rituximab Retreatment For ANCA-associated vasculitis, fixed retreatment not needed if naive B cells reappear Jun 05, 2021
Nintedanib Slows Decline in RA-Associated Interstitial Lung Disease Similar results to original larger trial seen in post-hoc analysis Jun 04, 2021
Oral JAK 1 Inhibitor Eases Spine Inflammation in Ankylosing Spondylitis Treatment with filgotinib resulted in significant improvements compared with placebo Jun 04, 2021
Even Exposure to Passive Smoking Increases Risk of RA Disease onset was earlier in women exposed to smoky rooms during childhood Jun 03, 2021
Rituximab a Hazard in RA Patients With COVID Poor outcomes were fourfold higher among rituximab users than for those on TNF inhibitors Jun 03, 2021
'Talents' Land U.S. Researcher in Prison Ohio MD pleaded guilty to lying on grant applications, planned to share research with China May 19, 2021
Op-Ed: Why the COVID Vaccine Didn't Work for Me Millions of transplant patients need to be informed that they may not get sufficient protection May 10, 2021
FDA Panel to Weigh Avacopan's Fate for ANCA Vasculitis Agency staff called out "interpretability" of phase III trial results ahead of Thursday's meeting May 05, 2021
'Dancing With the Stars' Judge Carrie Ann Inaba's Autoimmune Diseases TV host takes leave of absence May 04, 2021
Delayed Diagnosis Common in Spinal Ailment Typical 7-year delay after symptom onset leaves patients at risk for irreversible damage Apr 30, 2021
Perianal Involvement in Crohn’s Disease: How Bad for Prognosis? Poor outcomes noted, especially with severe phenotype Apr 14, 2021
Pegloticase Safe for Dialysis Patients With Gout Significant drop in monthly ESA dose seen after treatment, too Apr 09, 2021
For Enthesitis in Psoriatic Arthritis, Target IL-23 Targeted agent provides relief for many PsA patients Apr 08, 2021
Refractory IBD: The Case for Doubling Up on Drugs Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
Serious Infections Still Common in Vasculitis Cyclophosphamide induction was riskier than rituximab Mar 23, 2021
What to Tell Patients With Rheumatic/Musculoskeletal Diseases About COVID Vaccines New guidance from the American College of Rheumatology Mar 19, 2021
Vasculitis Rates Rise With Earth's Latitude Highest rates for giant cell arteritis seen in Scandinavia, lowest in Hong Kong Mar 17, 2021
Game Changer for Ulcerative Colitis Patients Failing Anti-TNF? JAK inhibitor helped when biologic didn't Mar 12, 2021
Study Confirms Risk-Adapted CRS Prophylaxis for Acute Leukemia Tocilizumab reduced severe cytokine release syndrome in children, young adults Mar 09, 2021
Combo Therapy Boosts Response in Uncontrolled Gout "Markedly higher" rate than with pegloticase alone Mar 02, 2021
Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
Anakinra for Gout Flares: Is There a Role? IL-1 blockade was not superior to triamcinolone, but does have advantages Feb 23, 2021
Lung Hemorrhage in Lupus: Which Patients Die? Risk factors include older age, longer disease duration, infection, and certain treatments Feb 20, 2021
Avacopan for ANCA Vasculitis: A New Treatment Paradigm? Remission rates not inferior to prednisone -- the "unthinkable" achieved Feb 17, 2021
Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
Colchicine for Early COVID-19? Trial May Support Oral Therapy at Home But some find science-by-press-release troubling Jan 26, 2021
IBD and COVID: Kids Do Well International registry shows older age, comorbidities are risks; anti-TNF might protect Jan 25, 2021
Copay Assistance Programs Help Patients but Confuse Them Too Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
Staying Safe in Lupus: Monitor Hydroxychloroquine Levels Limit the retinopathy risk while maintaining anti-thrombotic protection, study suggests Jan 11, 2021
